We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$36.5B
AUM Growth
+$3.93B
Cap. Flow
+$651M
Cap. Flow %
1.78%
Top 10 Hldgs %
7.68%
Holding
3,587
New
780
Increased
747
Reduced
671
Closed
866

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$223M
2
TJX icon
TJX Companies
TJX
+$191M
3
TDG icon
TransDigm Group
TDG
+$157M
4
IR icon
Ingersoll Rand
IR
+$155M
5
BP icon
BP
BP
+$152M

Sector Composition

Rank Sector Weight
1 Industrials 11.3%
2 Financials 10.99%
3 Technology 9.97%
4 Consumer Discretionary 9.35%
5 Healthcare 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNSO icon
1951
MINISO
MNSO
$3.55B
$306K ﹤0.01%
+28,549
New +$239K
BXC icon
1952
BlueLinx
BXC
$701M
$306K ﹤0.01%
4,304
+113
+3% +$7.7K
ADERW
1953
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$305K ﹤0.01%
1,212,710
EMN icon
1954
Eastman Chemical
EMN
$8.29B
$305K ﹤0.01%
+3,741
New +$301K
AGRO icon
1955
Adecoagro
AGRO
$1.31B
$305K ﹤0.01%
+36,746
New +$301K
BLKB icon
1956
Blackbaud
BLKB
$2.1B
$303K ﹤0.01%
5,150
-67,885
-93% -$3.8M
CBZ icon
1957
CBIZ
CBZ
$2.96B
$303K ﹤0.01%
+6,468
New +$307K
HBM icon
1958
Hudbay
HBM
$11.8B
$302K ﹤0.01%
+59,642
New +$287K
ARCO icon
1959
Arcos Dorados Holdings
ARCO
$1.66B
$302K ﹤0.01%
36,077
-32,751
-48% -$245K
BF.A icon
1960
Brown-Forman Class A
BF.A
$13B
$301K ﹤0.01%
+4,572
New +$312K
USPH icon
1961
US Physical Therapy
USPH
$1.22B
$300K ﹤0.01%
+3,700
New +$310K
CCSI icon
1962
Consensus Cloud Solutions
CCSI
$695M
$299K ﹤0.01%
5,558
-2,143
-28% -$117K
CNR
1963
Core Natural Resources Inc
CNR
$4.71B
$298K ﹤0.01%
4,588
-17,075
-79% -$1.15M
OXY icon
1964
Occidental Petroleum
OXY
$57.7B
$297K ﹤0.01%
4,719
-1,122,500
-100% -$76.4M
PMVP icon
1965
PMV Pharmaceuticals
PMVP
$67.2M
$297K ﹤0.01%
+34,147
New +$364K
BHE icon
1966
Benchmark Electronics
BHE
$2.94B
$297K ﹤0.01%
11,113
-6,836
-38% -$189K
VNDA icon
1967
Vanda Pharmaceuticals
VNDA
$314M
$296K ﹤0.01%
40,088
+29,970
+296% +$292K
ECVT icon
1968
Ecovyst
ECVT
$1.09B
$295K ﹤0.01%
33,339
+9,443
+40% +$87K
CNNE icon
1969
Cannae Holdings
CNNE
$675M
$295K ﹤0.01%
14,297
+4,583
+47% +$100K
AHRT
1970
AH Realty Trust
AHRT
$501M
$293K ﹤0.01%
+25,503
New +$294K
EFSC icon
1971
Enterprise Financial Services Corp
EFSC
$2.41B
$292K ﹤0.01%
+5,968
New +$296K
SCL icon
1972
Stepan Co
SCL
$1.48B
$292K ﹤0.01%
+2,742
New +$287K
TAC icon
1973
TransAlta
TAC
$3.92B
$291K ﹤0.01%
32,416
+5,378
+20% +$48.2K
IVZ icon
1974
Invesco
IVZ
$13.9B
$290K ﹤0.01%
+16,130
New +$276K
ATKR icon
1975
Atkore
ATKR
$3.17B
$289K ﹤0.01%
2,551
-170,435
-99% -$17.8M

Similar funds

Balyasny Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Balyasny Asset Management held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Balyasny Asset Management's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • Balyasny Asset Management's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
  • Balyasny Asset Management added most to Visa in Q4 2022, an estimated $223M increase.
  • Balyasny Asset Management's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
  • Balyasny Asset Management fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
  • Balyasny Asset Management's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
  • Balyasny Asset Management opened 780 new positions and closed 866 in Q4 2022.
  • Balyasny Asset Management's portfolio value rose 12% quarter-over-quarter to $36.5B.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.